• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INNOVA; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Model Number 26921
Device Problem Fracture (1260)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/16/2023
Event Type  Injury  
Event Description
It was reported that the stent fractured.An 8 x 60 x 75 innova self-expanding stent was selected for use in a percutaneous transhepatic biliary stent implantation in the stenosed right bile duct.When the stent was deployed, it was noted that the stent might have been fractured.Post-dilation was attempted with a balloon but failed.A non-boston scientific drainage catheter was placed into the left bile duct, and the procedure was completed with another innova self-expanding stent.There were no patient complications reported, and the patient was in stable condition following the procedure.
 
Manufacturer Narrative
Media analysis by manufacturer: the device was not returned for analysis; however, media was provided in the form of three photos and one video.The media provided clearly shows the stent, and it does appear to be fractured.
 
Event Description
It was reported that the stent fractured.An 8 x 60 x 75 innova self-expanding stent was selected for use in a percutaneous transhepatic biliary stent implantation in the stenosed right bile duct.When the stent was deployed, it was noted that the stent might have been fractured.Post-dilation was attempted with a balloon but failed.A non-boston scientific drainage catheter was placed into the left bile duct, and the procedure was completed with another innova self-expanding stent.There were no patient complications reported, and the patient was in stable condition following the procedure.It was further reported that the bile duct was 90% stenosed with severe biliary tortuosity.The procedure was completed without another innova self-expanding stent; only one drainage catheter was placed to end the procedure.The drainage catheter was not originally planned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INNOVA
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16897177
MDR Text Key314849308
Report Number2124215-2023-22669
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/09/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number26921
Device Catalogue Number26921
Device Lot Number0031002416
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/07/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age52 YR
Patient SexFemale
Patient Weight50 KG
-
-